You are here
WATCH THIS SPACE…. as the UQ Business School Enterprize Competition moves on
UQ Business School has decided to no longer run the Enterprize Competition.
UQ Business School is continuing to support the founding objectives of the competition by reallocating resources to a number of new programs and projects designed to enhance leadership and support business.
We thank you for your support of the Enterprize Competition over the past 10 years. If you have any questions, please feel free to contact Renee Ada in the Marketing department at firstname.lastname@example.org
UQ Business School's Enterprize Competition Winners 2011
The innovators behind commercialising a world-first drug to delay cataracts from forming, and slow their growth, have been named the 2011 winners of The University of Queensland (UQ) Business School's $100,000 ENTERPRIZE competition.
Academic Dean and Head of UQ Business School, Professor Iain Watson, congratulated the Adelaide-based Calpain Therapeutics team on winning Australia's richest business plan competition.
"Calpain Therapeutics is pioneering a novel drug with application to the eye health of people around the world,'' Professor Watson said.
"The proposition of the drug is to significantly slow down cataracts on their path to causing blindness.
"With severe cataracts the leading cause of blindness around the world, the Business School is proud to support such a visionary innovation."
Since its inception in 2000, the Enterprize competition has assisted many successful businesses, including Fusion Sport, Codesion (formerly CVSDude), BakBalls, last year's winner Southern Innovation and finalist last year Vaxxas (which is pioneering the Nanopatch needle-free vaccine delivery system).
The Enterprize 2012 website is currently under maintenance and will be back soon.